<PAGE>   1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                    FORM 10-Q

[X]  Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange
     Act of 1934

     For  the period ended February 28, 1998.

[ ]  Transition report pursuant to Section 13 or 15(d) of the Securities
     Exchange Act of 1934

     For the transition period from _____________ to ______________

     Commission File Number 0-5751
                            ------


                         COMPREHENSIVE CARE CORPORATION
                         ------------------------------
             (Exact name of registrant as specified in its charter)


          Delaware                                       95-2594724
          --------                                       ----------
(State or other jurisdiction                (I.R.S. Employer Identification No.)
 of incorporation or organ-
 ization)


              4200 West Cypress Street, Suite 300, Tampa, FL 33607
              ----------------------------------------------------
              (Address of principal executive offices and zip code)


                                 (813) 876-5036
                                 --------------
              (Registrant's telephone number, including area code)


         Indicate by check mark whether the registrant: (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                                                                Yes [X]   No [ ]

         Indicate the number of shares outstanding of each of the issuer's
classes of Common Stock, as of the latest practicable date:

                Classes                            Outstanding at April 10, 1998
                -------                            -----------------------------
Common Stock, par value $.01 per share                        3,460,560


<PAGE>   2

                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES

                                      Index
<TABLE>
<CAPTION>
                                                                         Page
<S>                                                                      <C>
PART I -  FINANCIAL INFORMATION

     Item 1. - Condensed Consolidated Financial Statements

          Condensed consolidated balance sheets,
             February 28, 1998 and May 31, 1997......................... 3

          Condensed consolidated statements of operations for
             the three and nine months ended February 28, 1998 
             and 1997................................................... 4

          Condensed consolidated statements of cash flows for
             the nine months ended February 28, 1998 and 1997........... 5

          Notes to condensed consolidated financial statements.......... 6-11

     Item 2. - Management's discussion and analysis of financial 
                 condition and results of operations.................... 11-19


PART II - OTHER INFORMATION

     Item 1. - Legal Proceedings........................................ 19

     Item 2. - Exhibits and Reports on Form 8-K......................... 20


     Signatures......................................................... 21
</TABLE>



                                        2
<PAGE>   3

PART I.  -  FINANCIAL INFORMATION

ITEM 1.  -  CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                (Dollars in thousands, except per share amounts)
<TABLE>
<CAPTION>
                                                                                 February 28,   May 31,
                                                                                     1998        1997
                                                                                     ----        ----
<S>                                                                              <C>           <C>     
ASSETS                                                                           (Unaudited)    (Note)
Current assets:
  Cash and cash equivalents ....................................................   $  3,554    $  3,991
  Accounts receivable, less allowance for
    doubtful accounts of $1,046 and $882 .......................................      2,291       1,988
  Other receivables ............................................................      2,451       2,486
  Property and equipment held for sale .........................................         --       2,797
  Other current assets .........................................................        277         259
                                                                                   --------    --------
Total current assets ...........................................................      8,573      11,521
                                                                                   --------    --------

Property and equipment .........................................................     11,155      10,138
Less accumulated depreciation and amortization .................................     (4,256)     (3,820)
                                                                                   --------    --------
Net property and equipment .....................................................      6,899       6,318
                                                                                   --------    --------
Noncurrent assets:
  Property and equipment held for sale .........................................      1,910       1,910
  Notes receivable .............................................................      1,922       1,941
  Goodwill, net ................................................................      1,319       1,567
  Cash and receivable withholdings .............................................      3,578         842
  Other assets .................................................................        597         647
                                                                                   --------    --------
Total noncurrent assets ........................................................      9,326       6,907
                                                                                   --------    --------
Total assets ...................................................................   $ 24,798    $ 24,746
                                                                                   ========    ========

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
  Accounts payable and accrued liabilities .....................................   $  4,506    $  5,152
  Accrued claims payable .......................................................      6,073       6,256
  Current maturities of long-term debt .........................................          2          46
  Unbenefitted tax refunds received ............................................     12,092      12,092
  Income taxes payable .........................................................        351         362
                                                                                   --------    --------
Total current liabilities ......................................................   $ 23,024    $ 23,908
                                                                                   --------    --------

Long-term liabilities:
  Long-term debt, excluding current maturities .................................      2,705       2,712
  Other liabilities ............................................................        642         696
                                                                                   --------    --------
Total long-term liabilities ....................................................      3,347       3,408
                                                                                   --------    --------

Stockholders' deficit:
  Preferred stock, $50.00 par value; authorized 60,000 shares; issued
    and outstanding 41,260 shares of Series A Non-Voting 4% Cumulative
    Convertible Preferred Stock at redemption value ............................      2,156       2,094
  Common stock, $.01 par value; authorized 12,500,000 shares; issued
    and outstanding 3,391,529 shares ...........................................         34          34
  Additional paid-in capital ...................................................     48,998      48,888
  Accumulated deficit ..........................................................    (52,761)    (53,586)
                                                                                   --------    --------
      Total stockholders' deficit ..............................................     (1,573)     (2,570)
                                                                                   --------    --------
Total liabilities and stockholders' deficit ....................................   $ 24,798    $ 24,746
                                                                                   ========    ========
</TABLE>

Note:    The balance sheet at May 31, 1997 has been derived from the audited
         financial statements at that date, but does not include all of the
         information and footnotes required by generally accepted accounting
         principles for complete financial statements.

                             See accompanying notes.



                                        3

<PAGE>   4

                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)
                (Dollars in thousands, except per share amounts)


<TABLE>
<CAPTION>
                                                                 Three Months Ended         Nine Months Ended
                                                                 ------------------         -----------------
                                                                     February 28,              February 28,
                                                                 1998           1997       1998            1997
                                                                 ----           ----       ----            ----
<S>                                                             <C>         <C>           <C>          <C>     
Revenues and gains:
  Operating revenues .......................................    $ 11,834    $  9,438      $ 34,433     $ 28,141

Costs and expenses:
  Direct healthcare expenses ...............................       9,071       8,101        28,733       24,690
  General and administrative expenses ......................       1,723       2,269         4,406        6,079
  Provision for doubtful accounts ..........................        (106)        (12)           51          189
  Depreciation and amortization ............................         210         182           628          520
  Restructuring expenses ...................................          --          --            --          195
                                                                --------    --------      --------     --------
                                                                  10,898      10,540        33,818       31,673
                                                                --------    --------      --------     --------

Income (loss) from operations ..............................         936      (1,102)          615       (3,532)

  Gain on sale of assets ...................................          13          16           169           42
  Loss on sale of assets ...................................          --          --            (8)         (12)
  Non-recurring gain (loss) ................................          --          --            --         (250)
  Interest income ..........................................         116          62           323          212
  Interest expense .........................................         (39)        (74)         (160)        (670)
                                                                --------    --------      --------     --------

Income (loss) before income taxes ..........................       1,026      (1,098)          939       (4,210)

Provision (benefit) for income taxes .......................          19           4            53         (341)
                                                                --------    --------      --------     --------

Income (loss) before extraordinary item ....................       1,007      (1,102)          886       (3,869)

Extraordinary item - gain on debenture exchange ............          --       2,191            --        2,191
                                                                --------    --------      --------     --------

Net income (loss) ..........................................       1,007       1,089           886       (1,678)

Dividends on convertible preferred stock ...................          21          10            62           10
                                                                --------    --------      --------     --------

Net income (loss) attributable to common
  stockholders .............................................    $    986    $  1,079      $    824     $ (1,688)
                                                                ========    ========      ========     ========


BASIC EARNINGS  PER SHARE
Income (loss) before extraordinary item ....................    $   0.29    $  (0.35)     $   0.24     $  (1.29)
Extraordinary item .........................................        0.00        0.70          0.00         0.73
                                                                --------    --------      --------     --------
Net Income (loss) ..........................................    $   0.29    $   0.35      $   0.24     $  (0.56)
                                                                ========    ========      ========     ========

DILUTED EARNINGS PER SHARE
Income (loss) before extraordinary item ....................    $   0.27    $  (0.35)     $   0.23     $  (1.29)
Extraordinary item .........................................    $   0.00    $   0.70      $   0.00     $   0.73
                                                                --------    --------      --------     --------
Net Income (loss) ..........................................    $   0.27    $   0.35      $   0.23     $  (0.56)
                                                                ========    ========      ========     ========
</TABLE>


                             See accompanying notes.



                                        4
<PAGE>   5

                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)
                             (Dollars in thousands)


<TABLE>
<CAPTION>
                                                                                Nine Months Ended
                                                                                -----------------
                                                                                   February 28,
                                                                                1998         1997
                                                                                ----         ----
<S>                                                                          <C>          <C>     
Cash flows from operating activities:
  Net income (loss) ....................................................     $   824      $(1,688)
Adjustments to reconcile net loss to net
  cash used in operating activities:
  Depreciation and amortization ........................................         627          520
  Provision for doubtful accounts ......................................          51          189
  Gain on Debenture conversion .........................................          --       (2,191)
  Gain on sale of assets ...............................................        (167)         (42)
  Loss on sale of assets ...............................................           9           12
  Changes in assets and liabilities:
    Accounts receivable ................................................        (354)           9
    Notes and other receivables ........................................          54         (733)
    Other current assets, restricted funds, and other non-current assets      (2,738)        (137)
    Accounts payable and accrued liabilities ...........................        (375)       1,069
    Other liabilities ..................................................        (380)        (208)
Increase in unbenefitted tax refunds received ..........................          --        5,074
Increase (decrease) in income taxes payable ............................         (11)         (50)
                                                                             -------      -------
  Net cash (used in) provided by operating activities ..................      (2,460)       1,824
                                                                             -------      -------

Cash flows from investing activities:
  Net proceeds from sale of property and equipment (operating and
  held for sale) .......................................................       2,966          409
  Additions to property and equipment ..................................      (1,110)        (293)
                                                                             -------      -------
    Net cash provided by investing activities ..........................       1,856          116
                                                                             -------      -------

Cash flows from financing activities:
  Bank and other borrowings ............................................          16           --
  Dividends on preferred stock .........................................          63           10
  Proceeds from the issuance of Common Stock ...........................         155        2,756
  Repayment of debt ....................................................         (67)      (5,373)
                                                                             -------      -------
    Net cash provided by (used in) financing activities ................         167       (2,607)
                                                                             -------      -------

Net decrease in cash and cash equivalents ..............................        (437)        (667)

Cash and cash equivalents at beginning of period .......................       3,991        4,433
                                                                             -------      -------

Cash and cash equivalents at end of period .............................     $ 3,554      $ 3,766
                                                                             =======      =======
</TABLE>


                             See accompanying notes.


                                        5

<PAGE>   6

                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                FEBRUARY 28, 1998
                                   (UNAUDITED)


NOTE -1- BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

         The condensed consolidated balance sheet as of February 28, 1998, and
the related condensed consolidated statements of operations and cash flows for
the three and nine month periods ended February 28, 1998 and 1997 are unaudited
and have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form
10-Q and Article 10 of Regulation S-X. In the opinion of management, all
adjustments necessary for a fair presentation of such financial statements have
been included. Such adjustments consisted only of normal recurring items. The
results of operations for the three and nine months ended February 28, 1998 are
not necessarily indicative of the results to be expected during the balance of
the fiscal year.

         The condensed consolidated financial statements do not include all
information and footnotes necessary for a complete presentation of financial
position, results of operations and cash flows in conformity with generally
accepted accounting principles. Notes to consolidated financial statements
included in Form 10-K for the year ended May 31, 1997 on file with the
Securities and Exchange Commission provide additional disclosures and a further
description of accounting policies.

         The Company's financial statements are presented on the basis that it
is a going concern, which contemplates the realization of assets and
satisfaction of liabilities in the normal course of business. The Company
incurred significant losses from operations in fiscal 1997. Income was recorded
for the second and third quarters of 1998 and a profit is reflected on a year to
date basis. The continuation of the Company's business is dependent upon the
resolution of operating and short-term liquidity problems and the realization of
the Company's plan of operations. These conditions may raise doubt about the
Company's ability to continue as a going concern. The consolidated financial
statements do not include any adjustments to reflect the possible future effects
on the recovery and classification of assets or the amount and classification of
liabilities that may result from the outcome of this uncertainty (see Note -2-
"Operating Losses and Liquidity").

         In 1997, the Financial Accounting Standards Board issued Statement of
Financial Accounting Standards No. 128, Earnings per Share. Statement 128
replaced the previously reported primary and fully diluted earnings per share.
Unlike primary earnings per share, basic earnings per share excludes any diluted
effects of options, warrants, and convertible securities. Diluted earnings per
share is very similar to the previously reported fully diluted earnings per
share. All earnings per share amounts for all periods have been presented, and
where necessary, restated to conform to the Statement 128 requirements. (See
Note -8-).

         The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the amounts reported in the financial statements and
accompanying notes. Actual results could differ from these estimates.

Note -2- Operating Losses and Liquidity

         At February 28, 1998, the Company had cash and cash equivalents of $3.6
million. During the nine months ended February 28, 1998, the Company used $2.5
million in its operating activities which includes $1.7 million for cash
restricted due to capitation contract requirements and provided $1.9 million
from its investing activities. The Company reported net income before
extraordinary items of $1.0 million for the quarter ended February 28, 1998,
versus a net loss of $1.1 million for the quarter ended February 28, 1997. The
Company recorded net income before extraordinary items and after dividends on
convertible, preferred stock of $0.8 million for the nine months ended February
28, 1998 versus a loss of $3.9 million before extraordinary items for the same
period of fiscal 1997. As a result, the Company has an accumulated deficit of
$52.8 million and a total stockholders' deficiency of $1.6 million as of
February 28, 1998. Additionally, the Company's current assets at February 28,
1998 amounted to approximately $8.6 million and current liabilities were
approximately $23.0 million, resulting in a working capital deficiency of
approximately $14.4 million and a negative current ratio of 1:2.7. The Company's
primary use of available cash resources is to continue to expand its behavioral
medicine managed care business and fund operations.


                                        6


<PAGE>   7

                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                FEBRUARY 28, 1998
                                   (UNAUDITED)


         During the third quarter of fiscal 1997, the Company completed its
Debenture Exchange Offer. In addition to recognizing a gain on the Exchange of
$2.2 million, the Exchange resulted in a reduction of debt of $6.8 million with
the remaining $2.7 million in Debentures due in 2010. The Debenture Exchange
will also result in a reduction of interest expense for future periods. The
bondholders also consented to the waiver and elimination of the Debenture
sinking fund. Annual sinking fund installments of 5% would have been payable
commencing in April 1996 and continuing annually through April 2009. During the
third quarter of fiscal 1997, the Company exchanged its Secured Convertible Note
into Series A Non-Voting 4% Cumulative Convertible Preferred Stock and also
exchanged a minority interest in one of its subsidiaries into 100,000 shares of
its Common Stock (see Note -3- "Acquisitions and Dispositions"). As a result of
the above transactions, current liabilities were reduced by $11.5 million,
non-current liabilities were increased by $1.6 million, and stockholders'
deficit was improved by $5.3 million. These transactions also reduced the
Company's future cash obligations with the significant reduction in debt,
interest expense, and future sinking fund requirements.

         The Company also has the following potential sources of cash to fund
additional operating needs:

         -     A firm commitment from a mutual fund to purchase, in a private
               placement, at least $5.0 million of 15%, fully secured Company
               notes, due no earlier than November 1998 if offered by the
               Company. 

         -     Included in assets held for sale (non-current) is one hospital
               facility designated as property and equipment held for sale with
               a net realizable value of $1.9 million. The Company expects to
               sell this facility during fiscal 1998.

         Additionally, the Company believes that it would be able to raise
additional working capital through either an equity offering or borrowings if it
so desired. However, the Company cannot state with any degree of certainty at
this time whether additional equity capital or working capital would be
available to it, and if available, would be at terms and conditions acceptable
to the Company. All of these potential sources of additional cash in fiscal 1998
are subject to variation due to business and economic influences outside the
Company's control.

         Based upon current levels of operation and cash on hand of $3.6 million
and cash anticipated to be internally generated from operations, the Company
believes that it has sufficient working capital to meet obligations as they
become due, however, the ultimate resolution of the Company's entitlement to
certain IRS refund claims or the occurrence of business or economic conditions
beyond the control of the Company or the loss of existing contracts from which
cash from operations is internally generated may adversely affect the adequacy
of such working capital.

         These conditions may raise substantial doubt about the Company's
ability to continue as a going concern. The accompanying Condensed Consolidated
Financial Statements do not include any adjustments to reflect the possible
future effects on the recoverability and classification of assets or the amount
and classification of liabilities that may result from the outcome of this
uncertainty.

         In fiscal 1993, the Company established a restructuring reserve to
address the Company's operational issues. The purpose of such reserve was for
the realignment of the Company's focus and business and the settlement and
disposition of certain non-performing and under-utilized assets. Most of the
Company's inpatient freestanding facilities have been sold. Management continues
to implement plans for expanding the Company's managed care and behavioral
medicine contract management operations. During fiscal 1997, the Company
established an additional restructuring reserve of $0.2 million for severance
and other cash outlays related to the planned closure and disposition of
contract units which occurred during the first quarter of fiscal 1997. The
following table sets forth the activity to the restructuring reserve during the
third quarter of fiscal 1998:

<TABLE>
<CAPTION>
                                                                 CHARGES
                                                                 -------
                                            NOVEMBER 30,                                     FEBRUARY 28,
                                                1997       INCOME     EXPENSE     PAYMENTS       1998
                                                ----       ------     -------     --------       ----
                                                                (AMOUNTS IN THOUSANDS)
<S>                                         <C>            <C>        <C>         <C>        <C> 
         Restructuring Reserve:
         ---------------------
         Severance..........................    $ 12       $  --       $  --        $ (12)       $  0
         Operations/corporate relocation....     168         (66)         --          (13)         89
                                                ----       -----       -----        -----        ----
         Totals.............................    $180       $ (66)      $  --        $ (25)       $ 89
                                                ====       =====       =====        =====        ====
</TABLE>


                                        7

<PAGE>   8

                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                FEBRUARY 28, 1998
                                   (UNAUDITED)


NOTE -3- ACQUISITIONS AND DISPOSITIONS

         On June 4, 1997, the Company sold its non-operating freestanding
facility located in Cincinnati, Ohio for a gain of $0.2 million. Proceeds from
the sale were utilized for working capital purposes.

         On August 12, 1996, the Company sold a non-operating facility in Costa
Mesa, California. As part of this transaction, the Company took back a note
equal to 83% of the selling price. The cash proceeds were utilized to retire
long-term debt and for working capital purposes.

         On July 25, 1996, the Company consented to closing the acquisition of
Healthcare Management Services, Inc., Healthcare Management Services of Ohio,
Inc., Healthcare Management Services of Michigan Inc. and Behavioral Healthcare
Management, Inc. (hereafter collectively referred to as "HMS"). The Company
consented to the closing, reserving its rights to assert certain claims against
the Sellers and others. (See Note -9- Commitments and Contingencies). HMS
contracts with commercial and governmental agencies to provide managed
behavioral health care programs to patients in Michigan and Ohio. Additionally,
HMS provides the following on a contract basis: case management
(pre-certification, concurrent review, quality assurance, retrospective chart
reviews, peer review and clinical audits as requested by their clients), claims
review, network development, credentialing and management of clinical services
for hospitals and community providers. The Company recorded the acquisition
using the purchase method of accounting. In conjunction with this acquisition,
the Company issued a net of 10,000 shares of its Common Stock after giving
effect to a settlement with one of the principals in the HMS transaction.

NOTE -4- PROPERTY AND EQUIPMENT HELD FOR SALE

         The Company has decided to dispose of certain freestanding facilities
and other assets (see Note -2- "Operating Losses and Liquidity"). Property and
equipment held for sale consisting of land, building, equipment and other fixed
assets with a historical net book value of approximately $2.7 million at
February 28, 1998 is carried at estimated net realizable value of approximately
$1.9 million. Operating expenses of the facilities designated for disposition
were $52,000 for the three months ended February 28, 1998.

         Property and equipment held for sale which are under contract and
expected to be sold within the next twelve month period are shown as current
assets on the consolidated balance sheets. Gains and losses on facilities have
been reflected in the statement of operations. Any impairments to the net
realizable value of property and equipment held for sale have also been recorded
in the statement of operations. There were no transactions affecting the
carrying value of property and equipment held for sale for the three months
ended February 28, 1998.

NOTE -5- RESTRICTED CASH AND RECEIVABLE WITHHOLDINGS

Restricted cash and receivable withholdings consist of the following:

<TABLE>
<CAPTION>
                                                                     February 28,        May 31,
                                                                         1998             1997
                                                                         ----             ----
                                                                         (Dollars in thousands)
<S>                                                                  <C>                 <C>   
Cash restricted to meet capitation-contract requirements ........      $ 1,819           $  133
Receivable (capitation) withholdings.............................        1,759              709
                                                                       -------           ------
Total restricted funds:..........................................      $ 3,578           $  842
                                                                       =======           ======
</TABLE>


NOTE -6- INCOME TAXES

         On July 20, 1995, the Company filed its Federal tax return for fiscal
1995 and subsequently filed Form 1139 "Corporate Application for Tentative
Refund" to carryback losses described in Section 172(f) requesting a refund to
the Company in the amount of $9.4 million. On September 20, 1996, the Company
filed its Federal income tax return for fiscal 1996, and subsequently filed Form
1139 "Corporate Application for Tentative Refund" to carryback losses described
under Section 172(f) requesting a refund to the Company in the amount of $5.5
million. Section 172(f)


                                        8
<PAGE>   9


                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                FEBRUARY 28, 1998
                                   (UNAUDITED)


provides for a 10-year net operating loss carryback for losses attributable to
specified liability losses. A specified liability loss is defined, in general,
as any amount otherwise allowable as a deduction which is attributable to (i) a
product liability or (ii) a liability arising under a federal or state law or
out of any tort if the act giving rise to such liability occurs at least three
years before the beginning of the taxable year. On August 30, 1995, the Company
also filed amended Federal tax returns for several prior fiscal years to
carryback losses under Section 172(f). The refunds requested on the amended
returns are approximately $6.2 million for 1986; $0.4 million for 1985; $0.7
million for 1983; and $0.4 million for 1982.

         There may be opposition by the Internal Revenue Service ("IRS") as to
the Company's ability to obtain benefits from refunds claimed under Section
172(f). Therefore, no assurances can be made as to the Company's entitlement to
all claimed refunds.

         In September 1996, the Company received a $5.4 million tentative refund
for fiscal 1996. Of this refund, $0.3 million has been recognized as a tax
benefit during the second quarter of fiscal 1997. In October 1995, the Company
received a $9.4 million tentative refund for fiscal 1995. Of this refund, $2.4
million was recognized as a tax benefit during the second quarter of fiscal
1996. Receipt of the 1996 and 1995 Federal refunds does not imply IRS approval.
Due to the lack of significant precedent regarding Section 172(f), the
unbenefitted amounts from fiscal 1996 and 1995 of $5.1 million and $7.0 million,
respectively, are reflected on the Company's consolidated balance sheet in
unbenefitted tax refunds received. In connection with the refund claims, the
Company paid contingency fees of $1.1 million and $1.9 million relating to the
fiscal 1996 and 1995 refunds, respectively. The Company expensed a pro rata
portion of the contingency fees as related tax benefits were recognized. The
remaining amount of $2.4 million is reflected in the Company's consolidated
balance sheet as other receivables. In the event the IRS Appeals Office
determines that the Company is not entitled to all or a portion of the
deductions under Section 172(f), this fee is reimbursable to the Company
proportionately.

         The Company is currently under audit by the IRS related to its fiscal
1996 and fiscal 1995 Federal income tax returns and the amended returns for
prior years. Neither the Company nor the IRS will be foreclosed from raising
other tax issues in regard to any audits of such returns, which also could
ultimately affect the Company's tax liability.

         The income tax reported by the Company differs from the customary
statutory rate of 34% due primarily to the utilization of net operating loss
carryforwards.

NOTE -7- ACCRUED CLAIMS PAYABLE

         Accrued claims payable represents the estimated ultimate net cost of
all reported and unreported benefits provided through February 28, 1998. The
accrued claims payable liability is estimated using statistical analyses based
on historical trends. Although considerable variability is inherent in such
estimates, management believes that the reported liability is adequate. The
estimates are continually reviewed and adjusted as necessary as experience
develops or new information becomes known, such adjustments are included in
current operations.


                                        9
<PAGE>   10


                 COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                FEBRUARY 28, 1998
                                   (UNAUDITED)


NOTE -8- EARNINGS PER SHARE

         The following table sets forth the computation of basic and diluted
earnings per share in accordance with Statement No. 128, Earnings Per Share:

<TABLE>
<CAPTION>
                                                                   Three Months Ended           Nine Months Ended
                                                                   ------------------           -----------------
                                                                      February 28,                 February 28,
                                                                   1998          1997          1998          1997
                                                                   ----          ----          ----          ----
<S>                                                             <C>           <C>            <C>          <C>     
Numerator:
  Income (loss) before Extraordinary item                       $ 1,007,000   $(1,102,000)   $  886,000   $(3,869,000)
  Less Preferred stock dividends                                    (21,000)      (10,000)      (62,000)      (10,000)
                                                                -----------   -----------    ----------   -----------
  Numerator for basic earnings per share-
    income (loss) available to common
    stockholders                                                $   986,000   $(1,112,000)   $  824,000   $(3,879,000)
  Extraordinary item                                                      0     2,191,000             0     2,191,000
                                                                -----------   -----------    ----------   -----------
  Net income (loss) available to common
    stockholders                                                $   986,000   $ 1,079,000    $  824,000   $(1,688,000)

Effect of dilutive securities:
  Preferred stock dividends                                     $    21,000   $         0    $        0   $         0
                                                                -----------   -----------    ----------   -----------
  Numerator for diluted earnings per share-
    income available to common stock-
    holders after assumed conversions                             1,007,000    (1,112,000)      824,000    (3,879,000)

Denominator:
  Denominator for basic earnings per
    share - weighted-average shares                               3,386,129     3,145,561     3,377,243     3,000,520
  Effect of dilutive securities:
    Employee stock options                                           53,586             0       171,619             0
    Convertible preferred stock                                     343,833             0             0             0
                                                                -----------   -----------    ----------   -----------
  Dilutive potential common shares                                  397,419             0       171,619             0
    Denominator for diluted earnings per
      share - adjusted weighted-average
      shares and assumed conversions                              3,783,548     3,145,561     3,548,862     3,000,520
                                                                ===========   ===========    ==========   ===========

BASIC EARNINGS  PER SHARE
Income (loss) before extraordinary item                         $      0.29   $     (0.35)   $     0.24   $     (1.29)
Extraordinary item                                                     0.00          0.70          0.00          0.73
                                                                -----------   -----------    ----------   -----------
Net Income (loss)                                               $      0.29   $      0.35    $     0.24   $     (0.56)
                                                                ===========   ===========    ==========   ===========

DILUTED EARNINGS PER SHARE
Income (loss) before extraordinary item                         $      0.27   $     (0.35)   $     0.23   $     (1.29)
Extraordinary item                                              $      0.00   $      0.70    $     0.00   $      0.73
                                                                -----------   -----------    ----------   -----------
Net Income (loss)                                               $      0.27   $      0.35    $     0.23   $     (0.56)
                                                                ===========   ===========    ==========   ===========
</TABLE>

The following number of potentially convertible shares of common stock related
to convertible preferred stock, convertible debentures, and stock options are as
follows at February 28, 1998:

<TABLE>
<CAPTION>
<S>                                                       <C>
For conversion of convertible preferred stock               343,833
For conversion of convertible debentures                     77,736
Outstanding stock options                                   672,682
Possible future issuances under stock option plan           677,111
                                                          ---------
  Total shares potentially convertible                    1,771,362
                                                          =========
</TABLE>


                                       10
<PAGE>   11


NOTE -9- COMMITMENTS AND CONTINGENCIES

         On September 6, 1996, the Company instituted an arbitration against the
HMS principals ("Sellers") with the American Arbitration Association in Orange
County, California seeking, among other things, reimbursement from the Sellers
for damages which the Company sustained by reason of the inaccuracies of the
representations and warranties made by the Sellers and for the indemnification
from each of the Sellers as provided for under the terms of the Stock Purchase
Agreement. One seller has settled his case with the Company. The arbitration
against the remaining Seller is presently pending. The Company does not believe
that the impact of these claims will have a material adverse effect on the
Company's financial position, results of operations and cash flows.

         In October 1994, the New York Stock Exchange, Inc. ("NYSE") notified
the Company that it was below certain quantitative and qualitative listing
criterion in regard to net tangible assets available to Common Stock and three
year average net income. The Listing and Compliance Committee of the NYSE has
determined to monitor the Company's progress toward returning to continuing
listing standards and has so indicated in approving the Company's most recent
Listing Application on December 30, 1996. Management believes, although no
assurance may be given, that the completion of the Company's Debenture Exchange
Offer positions the Company to seek additional equity and thereby satisfies the
Committee of the Company's progress. No assurance may be given that additional
equity may be obtained on terms favorable to the Company.

         On December 29, 1997, Ms. Kerri Ruppert, the former Chief Financial
Officer of the Company, commenced an action against the Company and its
Chairman, Chriss W. Street, in the Superior Court of the State of California
arising out of the termination of her employment on September 29, 1997. The
action alleges alternate causes of action based upon her employment relationship
with the Company and seeks unspecified damages for unpaid wages, unspecified
actual, compensatory and punitive damages; damages for emotional distress; and
costs, legal fees and penalties under applicable California law. The Company has
denied its liability, and has denied the principal allegations of the complaint.
The Company believes that it has good and meritorious defenses to this action.

         From time to time, the Company and its subsidiaries are also parties
and their property is subject to ordinary routine litigation incidental to their
business. In some pending cases, claims exceed insurance policy limits and the
Company or a subsidiary may have exposure to liability that is not covered by
insurance. Management believes that the outcome of such lawsuits will not have a
material adverse impact on the Company's financial statements.

NOTE -10- EVENTS SUBSEQUENT TO THE BALANCE SHEET DATE

         On March 31, 1998, the Company collected cash, totaling $1,949,800,
representing $1,936,800 in principal and $13,000 in interest in full settlement
of the 8% secured promissory note.

ITEM 2. - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND 
          RESULTS OF OPERATIONS

         This Quarterly Report on Form 10-Q includes forward-looking statements,
the realization of which may be impacted by certain important factors discussed
below under "Risk Factors -- Important Factor Related to Forward- Looking
Statements and Associated Risks" (page 16).

General

         Comprehensive Care Corporation ("CompCare") was founded 27 years ago to
provide fee-for-service treatment of alcohol abuse at inpatient hospitals. In
its early years, the Company grew rapidly and prospered due to the willingness
of insurance companies to reimburse the Company for long lengths of stay and at
very lucrative day rates. Over time, the Company diversified to provide a
spectrum of behavioral healthcare services including drug treatments, smoking
cessation and long-term rehabilitation. Beginning in the late 1980's and
accelerating into the 1990's, insurance companies implemented "managed care"
cost containment in behavioral healthcare. This led to the adoption of policies
aimed at reducing inpatient lengths of stay and day rates paid and encouraging
lower-cost, outpatient treatments, with consequent losses to the Company. The
Company embarked on a strategic plan to divest itself of its freestanding
facilities and to concentrate its efforts on its managed behavioral healthcare
business.


                                       11
<PAGE>   12


         In the first quarter of fiscal 1995, the CompCare Board appointed Mr.
Chriss W. Street as President and Chief Executive Officer to restructure the
Company's balance sheet and return operations to sustained profitability.
Through the first fiscal quarter of 1998, the Company divested most of its
unprofitable freestanding inpatient hospital facilities, reduced net debt by
93%, and resolved certain past IRS and legal issues. Operations were reorganized
around strategic investments in expertise and infrastructure that facilitated
the growth of the Company's managed behavioral healthcare business by 1,000%.

Global Restructuring

         In early fiscal 1995, management developed a "global restructuring"
plan intended to address the Company's immediate challenges and to return to a
base of profitability for future success. Management has achieved all of the
stated objectives in the global restructuring plan, including the restructuring
of the Company's financial obligations represented by the Company's 7 1/2%
Convertible Subordinated Debentures (the "Debentures") which occurred during the
third quarter of fiscal 1997.

         During fiscal 1997, the Company recorded $0.2 million in restructuring
charges related to the Company's closure of several contract units which
occurred during the first and second quarters of fiscal 1997. The components of
this charge were predominately severance to contract unit employees. Closure of
these units was either consistent with the Company's global restructuring plans
or resulted from contracts not renewed by host hospitals and will eliminate the
funding of operating losses and cash flow deficits required by these units.

         On June 4, 1997, the Company sold its non-operating freestanding
facility in Cincinnati, Ohio which had been closed in August, 1996 due to poor
performance. The Company utilized the proceeds received from the sale for
working capital and short-term investment purposes.

Third Quarter

         During the third fiscal quarter ended February 28, 1998, CompCare's
management continued to focus on achieving sustainable profitability. The
Company implemented its previously announced consolidation of certain financial
and operating functions from its corporate headquarters in Corona del Mar,
California to its rapidly growing managed care subsidiary headquartered in
Tampa, Florida. Management believes that increased communication and the
intensive involvement of corporate management in the direct operational aspects
of the business were key factors in the Company achieving its first back-to-back
operating profit in recent years.

         CompCare's mix of business remained at more than 80% managed care for
the quarter. The following table sets forth the distribution of operating
revenues for the selected quarterly periods:

<TABLE>
<CAPTION>
                                                                           Three months ended
                                                               -----------------------------------------
                                                               February 28,      May 31,    February 28,
                                                                   1998           1997          1997
                                                                   ----           ----          ----
         <S>                                                   <C>               <C>        <C>
         Managed care operations..........................          84%            78%           79%
         Provider operations..............................          16             22            21
                                                                   ---            ---           ---
         Totals...........................................         100%           100%          100%
                                                                   ===            ===           ===
</TABLE>

         Income from operations for the third quarter of fiscal 1998 was
$936,000 compared to a $674,000 profit for the second quarter of fiscal 1998,
and a $1,102,000 loss from operations for the comparable third quarter of fiscal
1997. Net Income before extraordinary items and after dividends on convertible,
preferred stock for the third quarter of 1998 was $986,000 or $.29 per share
compared to the $673,000 profit or $.20 per share for the second quarter of
fiscal 1998 and the $1,112,000 loss or $.35 per share for the comparable third
quarter of 1997.

RESULTS OF OPERATIONS

Statistical Information

         The following utilization statistics include data from all operations
including closures during the periods, joint ventures and closed facilities:


                                       12
<PAGE>   13

<TABLE>
<CAPTION>
                                                   Three Months Ended        Nine Months Ended
                                                   ------------------        -----------------
                                                      February 28,             February 28,
                                                    1998         1997         1998         1997
                                                    ----         ----         ----         ----
<S>                                              <C>          <C>          <C>          <C>      
Managed care operations (covered lives):
    Carve-out (capitated) ...................    1,045,996    1,232,068    1,045,996    1,232,068
    ASO services ............................      198,877        4,632      198,877        4,632
    EAP .....................................       62,399       66,998       62,399       66,998
    Blended products ........................            0      227,517            0      227,517
                                                 ---------    ---------    ---------    ---------
         Total ..............................    1,307,272    1,531,215    1,307,272    1,531,215
                                                 =========    =========    =========    =========

Behavioral medicine contracts:
    Patient days ............................        4,416        1,281       11,821        6,451
    Average occupied beds per contract ......           12            3           11            4
    Admissions ..............................          183          334          889        1,156
    Average length of stay (days) ...........         24.1          3.9         13.3          5.6
    Beds available at end of period .........           60           55           60           55

Freestanding facilities:
    Patient days ............................          476         1470         3088        4,577
    Occupancy rate ..........................           14%          43%          30%          38%
    Admissions ..............................           49          301          551          914
    Average length of stay (days) ...........          9.7          4.9          5.6          5.0
    Beds available at end of period .........           38           38           38           45
</TABLE>


Three Months Ended February 28, 1998 Compared To Three Months Ended February 28,
1997

<TABLE>
<CAPTION>
                                      Three months ended       Increase (Decrease)
                                      ------------------       -------------------
                                         February 28,
                                        1998      1997             $          %
                                        ----      ----          -------     ----
                                                (Amounts in thousands)
<S>                                    <C>       <C>            <C>         <C>
Operating revenues
  Managed care ....................    $ 9,993   $ 7,478        $ 2,515      34%
  Provider operations .............      1,841     1,960           (119)     (6)%
                                       -------   -------        -------     ---
     Net revenues .................     11,834     9,438          2,396      25%

Direct healthcare expenses ........      9,104     8,101          1,003      12%
General and administrative ........      1,690     2,269           (579)    (26)%
Other operating expenses ..........        104       170            (66)    (39)%
                                       -------   -------        -------     ---
  Operating income (loss) .........    $   936   $(1,102)       $ 2,038     185%
                                       =======   =======        =======     ===
</TABLE>

         Operating revenues increased by 25%, or $2.4 million, from the third
quarter of fiscal 1997, reflecting increases in the overall monthly payment rate
obtained from new contracts in the managed care division. The managed care
division posted an increase in operating revenues of 34%, or $2.5 million, for
the third quarter of fiscal 1998 as compared to the third quarter of fiscal
1997.

         Direct healthcare expenses increased by approximately 12%, or $1
million for the third quarter of fiscal 1998 compared to the third quarter of
fiscal 1997 due primarily to an increase of 34% in managed care operations which
reflects growth in the underlying business, offset by the elimination of
selected unprofitable contracts.

         General and administrative expenses decreased by approximately $0.6
million from the third quarter of fiscal 1997. This reduction in expense
reflects a decline in corporate overhead spending due primarily to the
consolidation of corporate and managed care finance functions in Tampa, Florida.

         During the third quarter of fiscal 1998, patient days of service for
behavioral medicine contracts increased 345% from 1,281 patient days to 4,416
patient days due to the implementation, during the first quarter of fiscal 1998,
of a high-volume contract with the State of Idaho. However, average net revenue
per patient day decreased 89% from the third quarter of fiscal 1997 due to a
lower per-patient revenue.


                                       13
<PAGE>   14


         During the third quarter of fiscal 1998, admissions for the
freestanding facility operated by the Company decreased to 49 from 301 in the
third quarter of the prior fiscal year. Average length of stay increased from
4.9 days to 9.7 days in the current quarter.

         The Company continues to focus its efforts toward providing effective
lower cost outpatient, partial hospitalization and daycare programs. It also
continues to strive to establish and maintain relationships and contracts with
managed care and others that pay for or broker such services.

Nine Months Ended February 28, 1998 Compared to Nine Months Ended February 28,
1997

<TABLE>
<CAPTION>
                                       Nine months ended       Increase (Decrease)
                                       -----------------       -------------------
                                         February 28,
                                        1998      1997             $          %
                                        ----      ----          -------     ----
                                                 (Amounts in thousands)
<S>                                    <C>       <C>            <C>         <C>
Operating revenues
  Managed care ....................    $28,545   $19,466        $ 9,079      47%
  Provider operations .............      5,888     8,675         (2,787)    (32)%
                                       -------   -------        -------     ---
     Net revenues .................     34,433    28,141          6,292      22%

Direct healthcare expenses ........     28,733    24,690          4,043      16%
General and administrative ........      4,406     6,079         (1,673)    (28)%
Other operating expenses ..........        679       904           (225)    (25)%
                                       -------   -------        -------     ---
  Operating income (loss) .........    $   615   $(3,532)       $ 4,147     117%
                                       =======   =======        =======     ===
</TABLE>

         The Company reported a pretax profit of approximately $1.0 million for
the nine months ended February 28, 1998 compared to the pretax loss of $4.2
million reported for the nine months ended February 28, 1997. Included in the
results for fiscal 1997 is a restructuring charge of $0.2 million, a legal
settlement of $0.3 million and $0.1 million in fees and expenses relating to the
Company's Exchange Offer of its Debentures.

         Operating revenues increased by 22%, or $6.3 million for the nine
months ended February 28, 1998 compared to the nine months ended February 28,
1997. The increase in operating revenues is attributable to an increase in
managed care operations of $9.1 million which was offset by a decline of $2.8
million related to provider operations which is comprised of behavioral medicine
contract units and one freestanding facility. Managed care revenues increased
47% due to increased rates for new contracts offset by a decrease in
non-profitable, lower rate contracts.

         Direct healthcare expenses increased by 16%, or $4.0 million for the
nine months ended February 28, 1998 as compared to the nine months ended
February 28, 1997. The increase in direct healthcare expenses is primarily
attributable to an increase in managed care operations which was partially
offset by a decline in direct healthcare expenses for provider operations. The
managed care increase reflects growth in the underlying business, offset by the
elimination of selected, unprofitable contracts. Covered lives decreased 223,943
or 15% due to cancellation of existing non-profitable, lower rate contracts.

         General and administrative expenses decreased by 28%, or $1.7 million
for the nine months ended February 28, 1998 as compared to the nine months ended
February 28, 1997. This reduction in expense reflects a decline in corporate
overhead spending due to corporate restructuring. Other operating expenses
declined by $0.2 million as a result of a decrease in the provision for doubtful
accounts arising from improved management of Company receivables. Interest
expense decreased by 80%, or $0.5 million for the nine months ended February 28,
1998 compared to the nine months ended February 28, 1997 as a result of the
Debenture Exchange in the third quarter of fiscal 1997.

         The Company's managed care operations contract with a variety of
sources on a capitated basis. The Company attempts to control its risk by
entering into contractual relationships with healthcare providers including
hospitals and physician groups on a sub-capitated, discounted fee for service or
per case basis. The Company believes that it distinguishes itself from its
competition by being the "science-based" provider of care by managing all
clinical programs based upon proven treatment technologies.


                                       14
<PAGE>   15


         During the first nine months of fiscal 1998, patient days of service
for behavioral medicine contracts increased by approximately 83% from 6,451
patient days to 11,821 patient days due to the implementation during the first
quarter of fiscal 1998 of a high-volume contract with the State of Idaho.
However, average net revenue per patient day decreased 87% from the first nine
months of fiscal 1997 due to a lower, per-patient revenue.

         Admissions at the freestanding facility decreased to 551 from 914 in
the first nine months of fiscal year 1998. Average length of stay increased to
5.6 from 5.0. Total patient days declined 1,489 days to 3,088 days in the first
nine months of fiscal 1998.

         The Company is taking steps designed to increase revenues, primarily
through the continued development of its behavioral medicine managed care
business. The Company is also implementing cost reduction measures including the
consolidation of selected corporate functions with the managed care operations
and achievement of various operating efficiencies. In addition, the Company sold
two poorly performing facilities in fiscal 1997 and one during the first quarter
of fiscal 1998. The Company owns two freestanding facilities. One of the two
owned facilities is currently operating and the other is held for sale. The
Company will continue to evaluate the performance of the remaining operating
facility in its respective market.

LIQUIDITY AND CAPITAL RESOURCES

         At February 28, 1998, the Company had cash and cash equivalents of $3.6
million. During the nine months ended February 28, 1998, the Company used $2.5
million in its operating activities and provided $1.9 million from its investing
activities. The Company reported net income before extraordinary items and after
dividends on convertible, preferred stock of $1.0 million for the quarter ended
February 28, 1998, versus a net loss of $1.1 million for the quarter ended 
February 28, 1997. The Company reported net income before extraordinary items
and after dividends on convertible, preferred stock of $0.8 million for the nine
months ended February 28, 1998, versus a loss of $3.9 million for the same
period of fiscal 1997. As a result, the Company has an accumulated deficit of
$52.8 million and a total stockholders' deficiency of $1.6 million as of
February 28, 1998. Additionally, the Company's current assets at February 28,
1998 amounted to approximately $8.6 million and current liabilities were
approximately $23.0 million, resulting in a working capital deficiency of
approximately $14.4 million and a negative current ratio of 1:2.7. The Company's
primary use of available cash resources is to continue to expand its behavioral
medicine managed care business and fund operations while it seeks to dispose of
its non-operating freestanding facility held for sale.

         During third quarter fiscal 1997, the Company completed its Debenture
Exchange Offer. In addition to recognizing a gain on the Exchange of $2.2
million, the Exchange resulted in a reduction of debt of $6.8 million with the
remaining $2.7 million in Debentures due in 2010. The Debenture Exchange will
also result in a reduction of interest expense for future periods. The
bondholders also consented to the waiver and elimination of the Debenture
sinking fund. Annual sinking fund installments of 5% would have been payable
commencing in April 1996 and continuing annually through April 2009. During the
third quarter of fiscal 1997, the Company exchanged its Secured Convertible Note
into Series A Non-Voting 4% Cumulative Convertible Preferred Stock and also
exchanged a minority interest in one of its subsidiaries into 100,000 shares of
its Common Stock (see Note -3- "Acquisitions and Dispositions"). As a result of
the above transactions, current liabilities were reduced by $11.5 million,
non-current liabilities were increased by $1.6 million, and stockholders'
deficit was improved by $5.3 million. These transactions also reduced the
Company's future cash obligations with the significant reduction in debt,
interest expense and future sinking fund requirements.

         The Company also has the following potential sources of cash to fund
additional operating needs:

         -    A firm commitment from a mutual fund to purchase in a private
              placement at least $5.0 million of 15%, fully secured Company
              notes, due no earlier than November 1998 if offered by the
              Company.
         -    Included in assets held for sale (non-current) is one hospital
              facility designated as property and equipment held for sale with a
              net realizable value of $1.9 million. The Company expects to sell
              this facility during fiscal 1998.


                                       15
<PAGE>   16


         Additionally, the Company believes that it would be able to raise
additional working capital through either an equity offering or borrowings if it
so desired. However, the Company cannot state with any degree of certainty at
this time whether additional equity capital or working capital would be
available to it, and if available, would be at terms and conditions acceptable
to the Company. All of these potential sources of additional cash in fiscal 1998
are subject to variation due to business and economic influences outside the
Company's control.

         Based upon current levels of operation and cash on hand of $3.6 million
and cash anticipated to be internally generated from operations, the Company
believes that it has sufficient working capital to meet obligations as they
become due; however, the ultimate resolution of the Company's entitlement to
certain IRS refund claims or the occurrence of business or economic conditions
beyond the control of the Company or the loss of existing contracts from which
cash from operations is internally generated may adversely affect the adequacy
of such working capital.

         These conditions may raise substantial doubt about the Company's
ability to continue as a going concern. The accompanying Condensed Consolidated
Financial Statements do not include any adjustments to reflect the possible
future effects on the recoverability and classification of assets or the amount
and classification of liabilities that may result from the outcome of this
uncertainty.

RISK FACTORS

IMPORTANT FACTORS RELATED TO FORWARD-LOOKING STATEMENTS AND ASSOCIATED RISKS

         This Quarterly Report on Form 10-Q contains certain forward-looking
statements that are based on current expectations and involve a number of risks
and uncertainties. Factors that may materially affect revenues, expenses and
operating results include, without limitation, the Company's success in (i)
disposing of its remaining freestanding facility on acceptable terms, (ii)
expanding the behavioral medicine managed care operations, (iii) securing and
retaining certain refunds from the IRS and certain judgments from adverse
parties in the legal proceedings described above, and (iv) maintaining the
listing of the Company's Common Stock on the NYSE.

         The forward-looking statements included herein are based on current
assumptions that competitive conditions within the healthcare industry will not
change materially or adversely, that the Company will retain key management
personnel, that the Company's forecasts will accurately anticipate market demand
for its services, that the IRS refunds are recoverable and that there will be no
material adverse change in the Company's operations or business. Assumptions
relating to the foregoing involve judgments that are difficult to predict
accurately and are subject to many factors that can materially affect results.
Budgeting and other management decisions are subjective in many respects and
thus susceptible to interpretations and periodic revisions based on actual
experience and business developments, the impact of which may cause the Company
to alter its budgets, which may in turn affect the Company's results. In light
of the factors that can materially affect the forward-looking information
included herein, the inclusion of such information should not be regarded as a
representation by the Company or any other person that the objectives or plans
of the Company will be achieved.

HISTORY OF LOSSES; UNCERTAINTY OF FUTURE PROFITABILITY

         As of February 28, 1998, the Company had a stockholders' deficiency of
$1.6 million, a working capital deficiency of approximately $14.4 million and a
negative current ratio of 1:2.7. Income from operations for the quarter ended
February 28, 1998 was $0.9 million. Present results of operations are not
necessarily indicative of anticipated future results of operations.

         There can be no assurance that the Company will be able to sustain
profitability and maintain positive cash flows from operations or that
profitability and positive cash flow from operations can be sustained on an
ongoing basis. Moreover, the level of profitability or positive cash flow cannot
accurately be predicted.

         The Company's lack of profitability has resulted in the Company failing
to satisfy listing standards of the NYSE. No assurance can be made that the
Common Stock will continue to trade on the NYSE or that the Company can satisfy
the comparable requirements of any other stock exchange or the NASDAQ stock
market.


                                       16
<PAGE>   17


GOING CONCERN

         The Company's independent auditors have included an explanatory
paragraph in their report on the Company's consolidated financial statements as
of May 31, 1997 that states that the Company's history of losses and
consolidated financial position raise substantial doubt about its ability to
continue as a going concern.

NEED FOR ADDITIONAL FUNDS; UNCERTAINTY OF FUTURE FUNDING

         In the past, the Company's negative cash flow from operations has
consumed substantial amounts of cash. The completion of the Debenture Exchange
Offer required substantial amounts of cash for the payment of $4.6 million of
default interest and/or payment in exchange for surrender of Debentures which
resulted in a depletion of the Company's cash resources.

         During prior fiscal years, a principal source of liquidity has been the
private sale of equity securities and debt securities convertible into equity.
Under the shareholder policies of the NYSE, the Company may not be able to
effect large placements of equity without shareholder approval, which, if not
obtained, may adversely affect the Company with respect to future capital
formation. In addition, issuance of additional equity securities by the Company
could result in substantial dilution to stockholders.

         The Company has received tax refunds for fiscal 1996 and 1995 in the
amounts of $9.4 million and $5.4 million, respectively. Such refunds are based
on loss carrybacks under Section 172(f) of the Internal Revenue Code. Any IRS
claim for return of all or any portion thereof could have an adverse effect on
the Company's cash flows. See "Taxes," below.

TAXES

         The Company has received tax refunds of approximately $14.8 million
from the carryback of fiscal 1996 and 1995 specified losses defined in Section
172(f). Section 172(f) provides for a 10-year net operating loss carryback for
losses attributable to specified liability losses. A specified liability loss is
defined, in general, as any amount otherwise allowable as a deduction which is
attributable to (i) a product liability, or (ii) a liability arising under a
federal or state law, or out of any tort if the act giving rise to such
liability occurs at least three years before the beginning of the taxable year.
Receipt of the 1996 and 1995 tax refunds does not imply IRS approval. The
proceeds to the Company of the 1995 refund were reduced by a $2.5 million offset
for the Company's outstanding payroll tax obligation to the Internal Revenue
Service ("IRS"), including interest, pursuant to a settlement agreement relating
to tax years 1983 through 1991. Also, a $3.0 million contingency fee was paid to
Deloitte & Touche, LLP from the 1995 and 1996 refund proceeds. Section 172(f) is
an area of the tax law without guiding legal precedent. There may be substantial
opposition by the IRS to all or a substantial portion of such claims, and no
assurances can be made as to the ability to retain tax refunds based on such
deductions. Although the Company is currently being audited by the IRS, neither
the Company nor the IRS will be precluded in any resultant tax audit from
raising these and additional issues.

         The Company may be unable to utilize some or all of its allowable tax
deductions or losses, which depends upon factors including the availability of
sufficient net income from which to deduct such losses during limited carryback
and carryover periods. Further, the Company's ability to use any Net Operating
Losses may be subject to limitation in the event that the Company issues or
agrees to issue substantial amounts of additional equity. The Company monitors
the potential for "change of ownership" and believes its financing plans as
contemplated will not cause a "change of ownership;" however, no assurances can
be made that future events will not act to limit the Company's tax benefits.

DEPENDENCE ON REIMBURSEMENT BY THIRD-PARTY PAYORS

         The Company's ability to succeed in increasing revenues may depend in
part on the extent to which reimbursement of the cost of such treatment will be
available from government health administration authorities, private health
insurers and other organizations. Third-party payors are increasingly
challenging the price of medical products and services.

UNCERTAINTY OF PRICING; HEALTHCARE REFORM AND RELATED MATTERS

         Managed care operations are at risk for costs incurred to supply agreed
upon levels of service. Failure to anticipate or control costs could materially
adversely affect the Company. Additionally, the business of providing services
on a full risk capitation basis exposes the Company to the additional risk that
contracts negotiated and entered


                                       17


<PAGE>   18


into may ultimately be determined to be unprofitable, and result in significant
losses by reason of unanticipated utilization levels requiring the Company to
deliver and provide services at capitation rates which do not account for or
factor in such utilization levels.

         The levels of revenues and profitability of healthcare companies may be
affected by the continuing efforts of governmental and third-party payors to
contain or reduce the costs of healthcare through various means. In the United
States, there have been, and the Company expects that there will continue to be,
a number of federal and state proposals to implement governmental controls on
the price of healthcare. It is uncertain what legislative proposals will be
adopted or what actions federal, state or private payors for healthcare goods
and services may take in response to any healthcare reform proposals or
legislation. The Company cannot predict the effect healthcare reforms may have
on its business, and no assurance can be given that any such reforms will not
have a material adverse effect on the Company.

DEPENDENCE ON KEY PERSONNEL

         The Company depends and will continue to depend upon the services of
its senior management and skilled personnel. The Company is presently in the
process of relocating certain significant management functions to Tampa,
Florida, where Comprehensive Behavioral Care, the Company's principal
subsidiary, is located. In connection with such relocation, the Company is in
the process of an executive search for a Chief Financial Officer. There is no
assurance that the Company will be able to successfully recruit an individual
who has the necessary background and experience in the managed healthcare field.

SHARES ELIGIBLE FOR FUTURE SALE

         The Company has issued or committed to issue approximately 344,000
shares related to the 4% convertible preferred stock, 78,000 shares related to
the conversion of debt or private placements, and options or other rights to
purchase approximately 1,350,000 shares. The Company may contemplate issuing
additional amounts of debt, equity or convertible securities in private
transactions in furtherance of fulfilling its future capital needs (see "Need
for Additional Funds: Uncertainty of Future Funding"). Issuance of additional
equity could adversely affect the trading prices of the Common Stock.

PRICE VOLATILITY IN PUBLIC MARKET

         The securities markets have from time to time experienced significant
price and volume fluctuations that may be unrelated to the operating performance
of particular companies. Trading prices of securities of companies in the
healthcare and managed care sectors have experienced significant volatility.

ANTI-TAKEOVER PROVISIONS

         The Company's Restated Certificate of Incorporation provides for 60,000
authorized shares of Preferred Stock, the rights, preferences, qualifications,
limitations and restrictions of which may be fixed by the Board of Directors
without any vote or action by the stockholders, which could have the effect of
diluting the Common Stock or reducing working capital that would otherwise be
available to the Company. There is currently issued and outstanding 41,260
shares of Preferred Stock designated as Series A Non-Voting 4% Cumulative
Convertible Preferred Stock. The Company's Restated Certificate of Incorporation
also provides for a classified board of directors, with directors divided into
three classes serving staggered terms. In addition, the Company's stock option
plans generally provide for the acceleration of vesting of options granted under
such plans in the event of certain transactions which result in a change of
control of the Company. In addition, Section 203 of the General Corporation Law
of Delaware prohibits the Company from engaging in certain business combinations
with interested stockholders. In addition, each share of the Company's Common
Stock includes one right on the terms, and subject to the conditions, of the
Rights Agreement between the Company and Continental Stock Transfer & Trust
Company. These provisions may have the effect of delaying or preventing a change
in control of the Company without action by the stockholders, and therefore
could adversely affect the price of the Company's Common Stock or the
possibility of sale of shares to an acquiring person.

CONTINUED LISTING ON NYSE

         The Company has been below certain continued listing criteria of the
NYSE since prior to October 1994. The continued listing of the Company's Common
Stock on the NYSE is subject to continual review and possible delisting upon
notices from the Listing and Compliance Committee of the NYSE.


                                       18


<PAGE>   19


LIMITATIONS ON THE DEDUCTIBILITY OF COMPENSATION UNDER CERTAIN CIRCUMSTANCES

         Pursuant to the 1993 Omnibus Budget Reconciliation Act, a portion of
annual compensation payable after 1993 to any of the Company's five highest paid
executive officers would not be deductible by the Company for federal income tax
purposes to the extent such officers' overall compensation exceeds $1.0 million
per executive officer. Qualifying performance-based incentive compensation,
however, would be both deductible and excluded for purposes of calculating the
$1.0 million base. The Board of Directors has determined that no portion of
anticipated compensation payable to any executive officer in 1998 would be
non-deductible.


PART II. - OTHER INFORMATION

ITEM 1. - LEGAL PROCEEDINGS

         On September 6, 1996, the Company instituted an arbitration against the
HMS principals ("Sellers") with the American Arbitration Association in Orange
County, California seeking, among other things, reimbursement from the Sellers
for damages which the Company sustained by reason of the inaccuracies of the
representations and warranties made by the Sellers and for the indemnification
from each of the Sellers as provided for under the terms of the Stock Purchase
Agreement. One seller has settled his case with the Company. The arbitration
against the remaining Seller is presently pending. The Company does not believe
that the impact of these claims will have a material adverse effect on the
Company's financial position, results of operations and cash flows.

         In October 1994, the New York Stock Exchange, Inc. ("NYSE") notified
the Company that it was below certain quantitative and qualitative listing
criterion in regard to net tangible assets available to Common Stock and three
year average net income. The Listing and Compliance Committee of the NYSE has
determined to monitor the Company's progress toward returning to continuing
listing standards, and has so indicated in approving the Company's most recent
Listing Application on December 30, 1996. Management believes, although no
assurance may be given, that the completion of the Company's Debenture Exchange
Offer will enable the Company to seek additional equity and thereby satisfy the
Committee of the Company's progress. No assurance may be given that additional
equity may be obtained on terms favorable to the Company.

         On December 29, 1997, Ms. Kerri Ruppert, the former Chief Financial
Officer of the Company, commenced an action against the Company and its
Chairman, Chriss W. Street, in the Superior Court of the State of California
arising out of the termination of her employment on September 29, 1997. The
action alleges alternate causes of action based upon her employment relationship
with the Company and seeks unspecified damages for unpaid wages, unspecified
actual, compensatory and punitive damages; damages for emotional distress; and
costs, legal fees and penalties under applicable California law. The action is
only in its formative stages. The Company has denied its liability, and has
denied the principal allegations of the complaint. The Company believes that it
has good and meritorious defenses to this action.

         From time to time, the Company and its subsidiaries are also parties
and their property is subject to ordinary routine litigation incidental to their
business. In some pending cases, claims exceed insurance policy limits and the
Company or a subsidiary may have exposure to liability that is not covered by
insurance. Management believes that the outcome of such lawsuits will not have a
material adverse impact on the Company's financial statements.


                                       19


<PAGE>   20


ITEM 2. - EXHIBITS AND REPORTS ON FORM 8-K

          (a) Exhibits

              27 Financial Data Schedules (filed herewith).

          (b) Reports on Form 8-K

              1)  The Company announced on August 19, 1997, that Stuart J.
                  Ghertner, Ph.D., had resigned as Chief Operating Officer of
                  the Company and as President of its wholly-owned subsidiary,
                  Comprehensive Behavioral Care, Inc., effective September 12,
                  1997. Dr. Ghertner will continue to be available to the
                  Company on a consulting basis.

              2)  The Company filed a current report on Form 8-K dated September
                  12, 1997, to report under Item 5, that the number of members
                  comprising the Board of Directors was increased to six; the
                  number of directors comprising Class II directors was
                  increased to two; and Mr. John A. McCarthy, Jr. was appointed
                  as a Class II director until the 1999 Annual Meeting of
                  Stockholders.

              3)  The Company filed a current report on Form 8-K dated October
                  3, 1997, to report under Item 5, that Ms. Kerri Ruppert,
                  Senior Vice President and Chief Financial Officer of the
                  Company, was separated from the Company, effective September
                  29, 1997, and that Ms. Carol Pollack was elected as the
                  Company's interim Chief Financial Officer, effective September
                  30, 1997. The Company also reported that Mr. W. James Nicol
                  resigned as a Class II director of the Company, and that the
                  vacancy would not be filled at this time, reducing the number
                  of Class II directors to one and the entire Board to five.

              4)  The Company filed a current report on Form 8-K dated December
                  8, 1997, to report under Item 5, the results of its Annual
                  Meeting of Stockholders which included the election of two
                  Class I Directors and the approval of an amendment to the
                  Company's 1995 Incentive Plan to increase the number of shares
                  authorized and available for issuance thereunder from 450,000
                  to 600,000.

              5)  The Company filed a current report on Form 8-K dated January
                  9, 1998, to report under Item 5, that Ms. Kerri Ruppert, the
                  former Chief Financial Officer of the Company, commenced an
                  action against the Company and its Chairman, Chriss W. Street,
                  arising out of the termination of her employment on September
                  29, 1997.


                                       20


<PAGE>   21


                                    SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                        COMPREHENSIVE CARE CORPORATION




April 14, 1998                          By /s/             CHRISS W. STREET
                                          --------------------------------------
                                                           Chriss W. Street
                                                              President and
                                                    Chief Executive Officer
                                              (Principal Executive Officer)




April 14, 1998                          By /s/            KEVIN M. CARNANAN
                                          --------------------------------------
                                                           Kevin M.Carnahan
                                              Vice President of Finance and
                                                   Chief Accounting Officer






                                       21


<PAGE>   22


                         COMPREHENSIVE CARE CORPORATION


                                  EXHIBIT INDEX

                                    FORM 10-Q

                    THIRD QUARTER ENDED FEBRUARY 28, 1998




EXHIBIT NO.             DESCRIPTION

27                      Financial Data Schedules (filed herewith).






                                       22